173 related articles for article (PubMed ID: 9482944)
1. Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.
Martens JR; Reaves PY; Lu D; Katovich MJ; Berecek KH; Bishop SP; Raizada MK; Gelband CH
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2664-9. PubMed ID: 9482944
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension.
Gelband CH; Reaves PY; Evans J; Wang H; Katovich MJ; Raizada MK
Hypertension; 1999 Jan; 33(1 Pt 2):360-5. PubMed ID: 9931130
[TBL] [Abstract][Full Text] [Related]
3. Permanent cardiovascular protection from hypertension by the AT(1) receptor antisense gene therapy in hypertensive rat offspring.
Reaves PY; Gelband CH; Wang H; Yang H; Lu D; Berecek KH; Katovich MJ; Raizada MK
Circ Res; 1999 Nov; 85(10):e44-50. PubMed ID: 10559146
[TBL] [Abstract][Full Text] [Related]
4. Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR.
Katovich MJ; Gelband CH; Reaves P; Wang HW; Raizada MK
Am J Physiol; 1999 Sep; 277(3):H1260-4. PubMed ID: 10484448
[TBL] [Abstract][Full Text] [Related]
5. Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense.
Iyer SN; Lu D; Katovich MJ; Raizada MK
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9960-5. PubMed ID: 8790439
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in the SHR.
Wang H; Reaves PY; Gardon ML; Keene K; Goldberg DS; Gelband CH; Katovich MJ; Raizada MK
Hypertension; 2000 Jan; 35(1 Pt 2):202-8. PubMed ID: 10642298
[TBL] [Abstract][Full Text] [Related]
7. Retrovirally mediated delivery of angiotensin II type 1 receptor antisense in vitro and in vivo.
Wang H; Lu D; Reaves PY; Katovich MJ; Raizada MK
Methods Enzymol; 2000; 314():581-90. PubMed ID: 10565039
[TBL] [Abstract][Full Text] [Related]
8. Delivery of angiotensin II type 1 receptor antisense inhibits angiotensin action in neurons from hypertensive rat brain.
Lu D; Raizada MK
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2914-8. PubMed ID: 7708748
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin I-converting enzyme antisense prevents altered renal vascular reactivity, but not high blood pressure, in spontaneously hypertensive rats.
Gelband CH; Wang H; Gardon ML; Keene K; Goldberg DS; Reaves PY; Katovich MJ; Raizada MK
Hypertension; 2000 Jan; 35(1 Pt 2):209-13. PubMed ID: 10642299
[TBL] [Abstract][Full Text] [Related]
10. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Li JS; Sharifi AM; Schiffrin EL
J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
[TBL] [Abstract][Full Text] [Related]
11. Endothelial-independent prevention of high blood pressure in L-NAME-treated rats by angiotensin II type I receptor antisense gene therapy.
Reaves PY; Beck CR; Wang HW; Raizada MK; Katovich MJ
Exp Physiol; 2003 Jul; 88(4):467-73. PubMed ID: 12861333
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy.
Pachori AS; Numan MT; Ferrario CM; Diz DM; Raizada MK; Katovich MJ
Hypertension; 2002 May; 39(5):969-75. PubMed ID: 12019278
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of hypertension by systemic delivery of retroviral vector containing type I angiotensin II receptor antisense cDNA.
Reaves PY; Wang HW; Katovich MJ; Gelband CH; Raizada MK
Methods; 2000 Nov; 22(3):211-8. PubMed ID: 11071816
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries.
Dohi Y; Criscione L; Pfeiffer K; Lüscher TF
J Cardiovasc Pharmacol; 1994 Sep; 24(3):372-9. PubMed ID: 7528292
[TBL] [Abstract][Full Text] [Related]
15. Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats.
Lu D; Raizada MK; Iyer S; Reaves P; Yang H; Katovich MJ
Hypertension; 1997 Sep; 30(3 Pt 1):363-70. PubMed ID: 9314418
[TBL] [Abstract][Full Text] [Related]
16. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
17. Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Kalliovalkama J; Kähönen M; Tolvanen JP; Wu X; Voipio J; Pekki A; Doris PA; Ylitalo P; Pörsti I
Pharmacol Toxicol; 2000 Jan; 86(1):36-43. PubMed ID: 10720105
[TBL] [Abstract][Full Text] [Related]
18. Age and hypertension differently affect coronary contractions to endothelin-1, serotonin, and angiotensins.
Tschudi MR; Lüscher TF
Circulation; 1995 May; 91(9):2415-22. PubMed ID: 7729029
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
20. Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense.
Pachori AS; Wang H; Gelband CH; Ferrario CM; Katovich MJ; Raizada MK
Circ Res; 2000 Jun; 86(11):1167-72. PubMed ID: 10850969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
